| TAH Drug Code | INS0501 |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. Adults: 500-1000 mL per dose, determined by the physician based on patient needs, administered subcutaneously, intramuscularly, or intravenously. Suitable as a solvent for dissolving or diluting injectable medications. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | None known. |
| Adverse Effects | Common: Phlebitis, Injection site disorder, Injection site extravasation, Hypervolemia. Serious: Congestive heart failure, Hypernatremia, Overhydration, Disseminated intravascular coagulation, Respiratory distress. |
| Pregnancy | Compatible |
| Lactation | Compatible |
| More Info | UpToDate |
| TAH Drug Code | INS0503 |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. Adults: 500-1000 mL per dose, determined by the physician based on patient needs, administered subcutaneously, intramuscularly, or intravenously. Suitable as a solvent for dissolving or diluting injectable medications. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | None known. |
| Adverse Effects | Common: Phlebitis, Injection site disorder, Injection site extravasation, Hypervolemia. Serious: Congestive heart failure, Hypernatremia, Overhydration, Disseminated intravascular coagulation, Respiratory distress. |
| Pregnancy | Compatible |
| Lactation | Compatible |
| More Info | UpToDate |
| TAH Drug Code | INS1002 |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. Adults: 500-1000 mL per dose, determined by the physician based on patient needs, administered subcutaneously, intramuscularly, or intravenously. Suitable as a solvent for dissolving or diluting injectable medications. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | None known. |
| Adverse Effects | Common: Phlebitis, Injection site disorder, Injection site extravasation, Hypervolemia. Serious: Congestive heart failure, Hypernatremia, Overhydration, Disseminated intravascular coagulation, Respiratory distress. |
| Pregnancy | Compatible |
| Lactation | Compatible |
| More Info | UpToDate |
| TAH Drug Code | INS1004 |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. Adults: 500-1000 mL per dose, determined by the physician based on patient needs, administered subcutaneously, intramuscularly, or intravenously. Suitable as a solvent for dissolving or diluting injectable medications. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | None known. |
| Adverse Effects | Common: Phlebitis, Injection site disorder, Injection site extravasation, Hypervolemia. Serious: Congestive heart failure, Hypernatremia, Overhydration, Disseminated intravascular coagulation, Respiratory distress. |
| Pregnancy | Compatible |
| Lactation | Compatible |
| More Info | UpToDate |
| TAH Drug Code | INS2 |
|---|---|
| Indications | 為生理食鹽水(N009997238) |
| Dosing | 20-1000 mL SC/IV/IV infusion. May use as diluent. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | No Data |
| Adverse Effects | No Data |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |
| TAH Drug Code | INS3 |
|---|---|
| Indications | ■Corneal edema ■Hyponatremia ■Hypovolemic shock |
| Dosing | Adult Parenteral nutrition: Sodium maintenance electrolyte requirement: IV: 1 to 2 mEq/kg/24 hours; customize amounts based on individual patient needs. Acute hyponatremia (serum sodium <130 mEq/L): Asymptomatic: IV 50 mL bolus over at least 5 minutes; monitor serum sodium every 1-2 hrs to assess need for additional treatment. Symptomatic: IV 100 mL over 10 minutes; if symptoms persist, may repeat up to a total of 3 doses over a period of 30 minutes; monitor serum sodium hourly to assess need for repeat treatment. Chronic hyponatremia Asymptomatic or mild to moderate symptoms, severe hyponatremia (serum sodium <120 mEq/L): IV Initial: 15 to 30 mL/hr with frequent (eg, every 2 to 4 hrs) serum sodium monitoring; or alternatively, 1 mL/kg bolus (maximum bolus: 100 mL) over 10 minutes every 6 hrs as needed. Severe symptoms (eg, seizures, obtundation, coma, respiratory arrest) or known intracranial pathology: IV 100 mL over 10 minutes; if symptoms persist, may repeat up to a total of 3 doses over a period of 30 minutes, Alternatively, some experts recommend 150 mL over 20 minutes, up to a total of 2 doses while measuring serum sodium between infusions. Hyponatremia in neonate: 3%NaCl infusion rate about 0.1-1 ml/kg/hour (max infusion rate 1 ml/kg/hour) and a central line is preferred for administration for 3% NaCl. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Hypersensitivity to sodium chloride or any component of the formulation; hypertonic uterus, hypernatremia, fluid retention |
| Adverse Effects | common ■Cardiovascular: Phlebitis ■Dermatologic: Injection site extravasation, Injection site reaction ■Endocrine metabolic: Hypervolemia serious ■Cardiovascular: Congestive heart failure ■Endocrine metabolic: Hypernatremia, Overhydration ■Hematologic: Disseminated intravascular coagulation ■Respiratory: Respiratory distress |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |
| TAH Drug Code | INS45 |
|---|---|
| Indications | 為0.45 % 食鹽水注射液(A036014277) |
| Dosing | IV infusion as needed. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | No Data |
| Adverse Effects | No Data |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |
| TAH Drug Code | INS5N |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. Adults: 500-1000 mL per dose, determined by the physician based on patient needs, administered subcutaneously, intramuscularly, or intravenously. Suitable as a solvent for dissolving or diluting injectable medications. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | None known. |
| Adverse Effects | Common: Phlebitis, Injection site disorder, Injection site extravasation, Hypervolemia. Serious: Congestive heart failure, Hypernatremia, Overhydration, Disseminated intravascular coagulation, Respiratory distress. |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |
| TAH Drug Code | INS5S |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. Adults: 500-1000 mL per dose, determined by the physician based on patient needs, administered subcutaneously, intramuscularly, or intravenously. Suitable as a solvent for dissolving or diluting injectable medications. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | None known. |
| Adverse Effects | Common: Phlebitis, Injection site disorder, Injection site extravasation, Hypervolemia. Serious: Congestive heart failure, Hypernatremia, Overhydration, Disseminated intravascular coagulation, Respiratory distress. |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |
| TAH Drug Code | INSO100 |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Hypernatremic and fluid retention syndromes. Immediately following surgery. |
| Adverse Effects | Common Cardiovascular: Phlebitis Dermatologic: Injection site extravasation, Injection site reaction Endocrine metabolic: Hypervolemia Serious Cardiovascular: Congestive heart failure Endocrine metabolic: Hypernatremia, Overhydration Hematologic: Disseminated intravascular coagulation Respiratory: Respiratory distress |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |
| TAH Drug Code | INSO250 |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Hypernatremic and fluid retention syndromes. Immediately following surgery. |
| Adverse Effects | Common Cardiovascular: Phlebitis Dermatologic: Injection site extravasation, Injection site reaction Endocrine metabolic: Hypervolemia Serious Cardiovascular: Congestive heart failure Endocrine metabolic: Hypernatremia, Overhydration Hematologic: Disseminated intravascular coagulation Respiratory: Respiratory distress |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |
| TAH Drug Code | INSO5 |
|---|---|
| Indications | Water or electrolyte replenishment. |
| Dosing | Individualised dosage. Sodium chloride 0.9% injection contains 154 mEq/L sodium and 154 mEq/L chloride. Calculated osmolarity is 308 mOsmol/L. |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | None known. |
| Adverse Effects | Common: Phlebitis, Injection site disorder, Injection site extravasation, Hypervolemia. Serious: Congestive heart failure, Hypernatremia, Overhydration, Disseminated intravascular coagulation, Respiratory distress |
| Pregnancy | Unknown |
| Lactation | Unknown |
| More Info | UpToDate |